Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 4/20 | 0.48 |
| ▸ | NOS3 | P29474 | 2/20 | 0.48 |
| ▸ | NOS2 | P35228 | 2/20 | 0.48 |
| ▸ | OTC | P00480 | 1/20 | 0.47 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | ARG1 | P05089 | 3/20 | 0.37 |
| ▸ | ARG2 | P78540 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitroarginine SCHEMBL28365071 | 1.00 | NOS1 (0.48) | NOS1NOS3NOS2OTCDDAH1 | |
| Nitroarginine SCHEMBL881062 | 1.00 | NOS1 (0.48) | NOS1NOS3NOS2OTCDDAH1 | |
| SCHEMBL607060 | 0.88 | NOS1 (0.46) | NOS1NOS3NOS2OTCDDAH1 | |
| SCHEMBL5983469 | 0.88 | NOS1 (0.46) | NOS1NOS3NOS2OTCDDAH1 | |
| L-Name SCHEMBL3034749 | 0.84 | NOS1 (0.41) | NOS1NOS3NOS2OTC | |
| L-Name SCHEMBL14751988 | 0.84 | NOS1 (0.41) | NOS1NOS3NOS2OTC | |
| L-Name SCHEMBL25310005 | 0.83 | NOS1 (0.40) | NOS1NOS3NOS2OTC | |
| L-Name SCHEMBL18812631 | 0.83 | NOS1 (0.40) | NOS1NOS3NOS2OTC | |
| SCHEMBL608402 | 0.81 | NOS1 (0.49) | NOS1 | |
| Arginine SCHEMBL1487699 | 0.80 | NOS1 (0.52) | NOS1NOS3NOS2OTCDDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2046 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727356-A2 | SYNTHETIC ANTIFREEZE GLYCOPROTEINS WITH ICE-BINDING ACTIVITY | University of Utah Research Foundation (US) | 2026-04-22 | — | — | EP | claimed |
| US-12590123-B2 | Compounds and methods for treating cancer, viral infections, and allergic conditions | WASHINGTON UNIVERSITY (US) | 2026-03-31 | — | — | US | claimed |
| EP-4709378-A1 | COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2026-03-18 | — | — | EP | claimed |
| US-12520839-B2 | Methods and compositions for cryopreservation of cell therapies | THE GEORGE WASHINGTON UNIVERSITY (US) | 2026-01-13 | — | — | US | claimed |
| EP-4649136-A1 | GENETIC MODIFICATION OF MICROBES FOR PRODUCTION OF NITROGEN AND CARBON-CONTAINING COMPOUNDS | Fertis India Pvt Ltd (IN) | 2025-11-19 | — | — | EP | claimed |
| US-20250257093-A1 | BETULASTATIN COMPOUNDS | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2025-08-14 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | WASHINGTON UNIVERSITY | 2025-05-29 | — | — | US | claimed |
| EP-4554947-A1 | PROTEASE/ENZYME CLEAVABLE LINKER-PAYLOADS AND PROTEIN CONJUGATES | Sutro Biopharma, Inc. (US) | 2025-05-21 | — | — | EP | claimed |
| CN-119948030-A | Protease/enzyme cleavable linker-payload and protein conjugates | 苏特罗生物制药公司 | 2025-05-06 | — | — | CN | claimed |
| WO-1996002241-A1 | USE OF NITROGEN OXIDE SPECIES AND ADDUCTS TO INHIBIT SKELETAL MUSCLE CONTRACTION | DUKE UNIVERSITY (US) | 1996-02-01 | — | — | WO | claimed |
| US-5439938-A | Treating priapism by applying to erect penis an inhibitor of NO synthetase to cause penis to become flaccid | THE JOHNS HOPKINS UNIVERSITY (US) | 1995-08-08 | — | — | US | claimed |
| EP-0603335-A4 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE. | US HEALTH (US) | 1995-07-05 | — | — | EP | claimed |
| EP-0603335-A1 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-06-29 | — | — | EP | claimed |
| US-5266594-A | For treatment of stroke or nervous system disorders such as Alzheimer's disease and Huntington's disease | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1993-11-30 | — | — | US | claimed |
| US-5212287-A | Multistage synthesis of oligopeptides with protection of side groups then deprotection after reaction | IMMUNETECH PHARMACEUTICALS, INC. (US) | 1993-05-18 | — | — | US | claimed |
| WO-1993005775-A1 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-04-01 | — | — | WO | claimed |
| EP-0399885-A1 | Tripeptide, its process of preparation and its use | RHONE-POULENC CHIMIE (FR) | 1990-11-28 | — | — | EP | claimed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | claimed |
| EP-0154581-B1 | ALPHA-CHLORINATED CARBONATES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION TO THE PROTECTION OF AMINIC FUNCTIONS IN AMINO ACIDS | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1988-06-08 | — | — | EP | claimed |